Rimantadine
Kathryn Dzintars, Pharm.D., BCPS, Paul G. Auwaerter, M.D.
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
- Influenza A
- Treatment for adults ≥17 years
- Prophylaxis: adults and children ≥1 year.
- CDC has not recommended adamantanes for seasonal influenza since 2005–06 because of widespread resistance; high-level resistance persists.[6]
- WHO 2024 did not consider amantadine or rimantadine because of widespread global resistance.[7]
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2026 Unbound Medicine, Inc. All rights reserved
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.